Mark For: AMPEL GENOMIC PLATFORM® trademark registration is intended to cover the categories of providing temporary use of a suite of non-downloadable computer software applications for grouping and categorizing human genes according to their biological function, analyzing the role of genes in promoting or inhibiting disease activity associated with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases and scoring such genes based on their role in promoting or inhibiting such disease activity, identifying blood and non-blood cells within the gene sequences contained in human tissues and organs, and analyzing genes and genetic profiles to assess disease activity in patients suffering from autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases, and assessing the efficacy of pharmaceuticals, drug therapies and treatments to treat such diseases.
Status
2020-11-27 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use
Yes
Current Use
Yes
Intent To Use
No
Filed ITU
No
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Patrick C. Asplin
Timeline
2018-10-29
Date of First Use
2018-10-29
Date of Use In Commerce
2020-11-24
Application Filed
2020-11-27
Location: NEW APPLICATION PROCESSING
2020-11-27
Status: Live/Pending
2020-11-27
Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
PATRICK C. ASPLIN FLORA PETTIT 530 EAST MAIN STREET CHARLOTTESVILLE, VA 22902
Good, Services, and Codes
International Codes:
42
U.S. Codes:
100,101
Type Code
Type
GS0421
Providing temporary use of a suite of non-downloadable computer software applications for grouping and categorizing human genes according to their biological function, analyzing the role of genes in promoting or inhibiting disease activity associated with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases and scoring such genes based on their role in promoting or inhibiting such disease activity, identifying blood and non-blood cells within the gene sequences contained in human tissues and organs, and analyzing genes and genetic profiles to assess disease activity in patients suffering from autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases, and assessing the efficacy of pharmaceuticals, drug therapies and treatments to treat such diseases
D10000
"GENOMIC PLATFORM"
Trademark Filing History
Description
Date
Proceeding Number
NEW APPLICATION ENTERED IN TRAM
2020-11-27
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.